Corporate Alliance Partners

&Alliance Team

Corporate Alliance Partners

IP Nexus Logo

‘We support Japanese technology companies to get a head start’

IP Nexus helps Japanese technology companies get a head start and provide value-driven returns to investors and other stakeholders. If you’re interested, please feel free to get in touch.
IP Nexus is an IP commercialization company that builds successful startup companies by collaborating with universities and research institutes to unlock the commercial potential of new technologies and create valuable returns for investors and other stakeholders. With a focus on technology and life sciences, IP Nexus works with universities to identify high-potential inventions at an early stage and provides the commercial direction, fundraising expertise, and management talent necessary to build outstanding companies. 
CleanHearing is one of those IP companies we are investing in as well.

Seedil Logo

‘We are excited about Israeli B2B technology’

SeedIL Ventures strives to invest in early-stage Israeli startups, by co-investing with top-tier funds. They are situated in Tel Aviv, the heart of the entrepreneurial ecosystem. Their amazing track record shows their expertise in venture capital and their ability to detect potential future Unicorns.


Mentha Partners Logo

‘Hong Kong-based company investing in disruptive blockchain B2B’

Mentha was founded upon a vision to be a front-runner of traditional finance’s (TradFi) inevitable transition to a blockchain-based ecosystem. They believe in the efficiency of a distributive-ledger network and the effectiveness of immutable digital smart contracts. Mentha entered the digital asset space with proprietary trading in Q1 2017 which led to special opportunity investing.


‘We have the final piece of tumor immunology.’

ImmuniT Research is extending an invitation to who share our vision of addressing global health issues. Our approach involves advancing data-driven immunology and measuring the impact of immunity, with a core emphasis on leveraging patented technology for tumor immunotherapy. By targeting a distinct subset of CD4 T cells, we aim to enhance the survival rates of cancer patients. Join us on this transformative journey by becoming a valued partner in our mission.The briefing will take place at 3:00 PM on December 12th, local time in San Francisco.

ImmuniT-Exective Summary / ImmuniT事業内容



In the rapidly changing landscape of future business, we will forge tangible and intangible assets for sustainable leaps forward.

To triumph in the competitive survival of business in this world and to sustainably propel forward, powerful tools are indispensable.
Intangible assets like purpose, brand, strategy, and communication are complemented by tangible assets such as digital services and design.
At UGOH, we assess each client company’s current state and WILL (intent) to create the optimal arsenal and support its implementation.

Social contributions

We contribute to the development of local communities, the preservation of the global environment, and the promotion of art, culture, and sports.


Sports Promotion


Independence Support

Affiliated partners


Swiss-Japanese Chamber of Commerce and Industry


Alliance Partners